Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 217 results for "harvard bone marrow initiative"

11 Lessons From the Biggest Pitch Contest of All-Time

The global capital of entrepreneurship last week was….Buffalo, N.Y. As part of a billion-dollar initiative to kickstart the western New York economy, Buffalo hosted the biggest pitchcontest ever: $5 million, doled out to 11 startups last Thursday, ... Forbes.com, 1 month ago

2 images for "harvard bone marrow initiative"

Medagadget.com, 1 month ago
Boston Globe, 2 months ago
A.M. Best

MS Research Highlights in 2014 Offer New Leads in Stopping MS, Restoring Function Lost, and Ending MS Forever

In 2014, the National Multiple Sclerosis Society invested $50.6 million in 380 new and ongoing research projects and initiatives. Here is a brief summary of the research highlights reflecting the Society's commitment to pursue promising ...
 Red Orbit3 weeks ago MS Research Highlights In 2014 That Offer New Leads In Stopping MS, Restoring Function Lost, And Ending MS Forever  Pharmacy Times2 weeks ago
[x]  

A New Model of the Pathology of the JC Virus

Valeo, Tom Back to Top | Article Outline ARTICLE IN BRIEF A research team developed a mouse model of the JC virus, which suggests that the virus multiplies primarily in astrocytes, rather than oligodendrocytes. Neuroinfectious disease experts ...
 Neurology Today1 week ago

Expert in Immune Responses in Stem Cell Transplantation Joins UPCI

UPMC/University of Pittsburgh Schools of the Health Sciences PITTSBURGH, Dec. 17, 2014 - Warren Shlomchik, M.D., a leading expert in investigating the immunologic mechanisms underlying graft-versus-host-disease (GVHD), a common complication for some ...
 Noodls1 week ago

New Follow-Up Data for IMBRUVICA® (ibrutinib) Presented at ASH Show Longer Term Efficacy in Patients with..

/PRNewswire/ -- Data confirms consistency of IMBRUVICA as an effective treatment option for patients with these challenging blood cancers Note: This press release corresponds to ASH abstracts 3331 and 4453 Janssen-Cilag International NV ...
 ADVFN India2 weeks ago
[x]  

Narrow subset of cells is responsible for metastasis in multiple myeloma, study finds

PUBLIC RELEASE DATE: 7-Dec-2014 Although it is among the most highly metastatic of all cancers, multiple myeloma is driven to spread by only a subset of the myeloma cells within a patient's body, researchers at Dana-Farber Cancer Institute have ...
 EurekAlert!2 weeks ago

PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

Original Article Stephen M. Ansell, M.D., Ph.D., Alexander M. Lesokhin, M.D., Ivan Borrello, M.D., Ahmad Halwani, M.D., Emma C. Scott, M.D., Martin Gutierrez, M.D., Stephen J. Schuster, M.D., Michael M. Millenson, M.D., Deepika Cattry, M.S., ...
 New England Journal of Medicine2 weeks ago

Screening for Matrix Effect in Leukemia Subtypes Could Sharpen Chemotherapy Targeting

Published: December 5, 2014. Location, location, location goes the old real estate proverb but cancer also responds to its neighborhood, particularly in the physical surroundings of bone marrow cells where human myeloid leukemias arise and ...
 ScienceNewsline3 weeks ago

Stemline Therapeutics Announces Multiple Preclinical Presentations Highlighting Its Pipeline of IL-3R-Directed Therapeutics at the American Society of Hematology (ASH) Annual Meeting

NEW YORK, Dec. 5, 2014 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. ( Nasdaq:STML ), announced today that results from multiple ongoing preclinical studies were selected for presentation at the 2014 American Society of Hematology (ASH) Annual ...
 Reliance Trust3 weeks ago Stemline Therapeutics, Inc. Announces Multiple Preclinical Presentations Highlighting Its Pipeline Of IL-3R-Directed Therapeutics At The American Society of Hematology Annual Meeting  BioSpace3 weeks ago STEMLINE THERAPEUTICS : Announces Multiple Preclinical Presentations Highlighting Its Pipeline of IL-3R-Directed Therapeutics at the American Society of Hematology (ASH) Annual Meeting  4 Traders3 weeks ago
[x]  

Missing Piece of Myeloma Puzzle Defined

Image Tools A new retrospective cohort study has for the first time defined the clinical course of light-chain smoldering multiple myeloma—i.e., the disease stage preceding light-chain multiple myeloma. A subset of patients with idiopathic ...
 Oncology Times3 weeks ago ONLINE FIRST: Missing Piece of Myeloma Puzzle Defined  Oncology Times1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less